Literature DB >> 30507250

Fusarium oxysporum is an onychomycosis etiopathogenic agent.

Flávia F Veiga1, Lidiane V de Castro-Hoshino2, Francielle Sato2, Amanda Bombassaro3, Vânia A Vicente3, Vanessa Mendes1, Mauro L Baesso2, Melyssa Negri1, Terezinha Ie Svidzinski1.   

Abstract

AIM: To evaluate and characterize the etiopathogenesis of the fusarial onychomycosis in an ex vivo study through fragments of sterile human nail, without the addition of any nutritional source. MATERIALS &
METHODS: The infection and invasion of Fusarium oxysporum in the nail were evaluated by scanning electron microscopy (SEM), CFU, matrix, histopathology and Fourier Transform Infrared Spectrometer coupled to an equipment with diamond accessory (FTIR-ATR).
RESULTS: F. oxysporum infected and invaded across the nail, regardless of application face. However, the dorsal nail surface was the strongest barrier, while the ventral was more vulnerable to infection and invasion process. The fungal-nail interaction resulted in the formation of a dense biofilm.
CONCLUSION: F. oxysporum infect and invade the healthy human nail, resulting in biofilm formation. Therefore, F. oxysporum is likely a primary onychomycosis agent.

Entities:  

Keywords:  ; biofilm; nail; onychomycosis

Mesh:

Year:  2018        PMID: 30507250     DOI: 10.2217/fmb-2018-0245

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  2 in total

1.  Human Nails Permeation of an Antifungal Candidate Hydroalcoholic Extract from the Plant Sapindus saponaria L. Rich in Saponins.

Authors:  Vanessa Mendes; Flávia Franco Veiga; Lidiane Vizioli de Castro-Hoshino; Francielle Sato; Mauro Luciano Baesso; Beatriz Vesco; Elton Cruz; Izabel Cristina Piloto Ferreira; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Molecules       Date:  2021-01-05       Impact factor: 4.411

Review 2.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.